Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bispecific antibodies
bispecific antibodies
AbbVie to pay Genmab $750M upfront to form bispecific R&D pact
Fierce Biotech
Wed, 06/10/20 - 11:01 am
AbbVie
bispecific antibodies
cancer
Genmab
Regeneron
epcoritamab
Sanofi sharpens focus on bispecifics, and China, with Alphamab deal
Endpoints
Wed, 06/10/20 - 10:41 am
Sanofi
China
Alphamab Oncology
breast cancer
bispecific antibodies
Roche pens $2B biobucks pact with Innovent Biologics for bispecific and cell therapies
Fierce Biotech
Tue, 06/9/20 - 12:17 pm
Roche
Innovent Biologics
China
bispecific antibodies
cell therapy
Johnson & Johnson's Oncology Team Posts Promising Cancer Trial Results
Motley Fool
Tue, 05/19/20 - 11:30 pm
JNJ
Multiple Myeloma
bispecific antibodies
JNJ-5957
teclistamab
clinical trials
Roche flashes new 16-week bispecific AMD data, setting eyes on pair of PhIII trials
Endpoints
Wed, 05/6/20 - 12:17 pm
Roche
clinical trials
bispecific antibodies
faricimab
wet age-related macular degeneration
ASH2019 – Regeneron takes the bispecific baton and runs
EP Vantage
Wed, 12/11/19 - 10:21 am
ASH2019
Regeneron
Xencor
bispecific antibodies
REGN1979
lyphoma
ASH: Amgen's BiTE stalls multiple myeloma relapse in mice in combo with BMS' Revlimid
Fierce Biotech
Mon, 12/9/19 - 09:53 am
Amgen
ASH2019
bispecific antibodies
AMG 701
Multiple Myeloma
Merus charts early promise for cancer drug targeting NRG1 fusions
Fierce Biotech
Mon, 10/28/19 - 10:40 am
Merus
bispecific antibodies
zenocutuzumab
NRG1 fusion
UCB's bispecific beats J&J's Stelara in psoriasis phase 3
Fierce Biotech
Fri, 10/18/19 - 07:47 pm
UCB Pharma
bispecific antibodies
bimekizumab
JNJ
Stelara
psoriasis
Glenmark spin-out aims to challenge Amgen, others in cancer bispecific field
Biopharma Dive
Tue, 10/15/19 - 10:21 pm
Glenmark
Ichnos Sciences
India
Amgen
oncology
Regeneron
bispecific antibodies
Overcoming Cancer Drug Resistance with A Bispecific Inhibitor
Xtalks
Wed, 09/25/19 - 10:21 am
oncology
drug resistance
Kitov
cancer
bispecific antibodies
Lilly drops PD-L1/TIM-3 bispecific from clinical pipeline
Fierce Biotech
Tue, 07/30/19 - 11:23 am
Eli Lilly
bispecific antibodies
solid tumors
Affimed scraps T-cell engager program, parts company with CSO
Fierce Biotech
Thu, 05/23/19 - 11:06 pm
Affimed
bispecific antibodies
T-cell engager
cancer
Merck KGaA retools F-star pact, walks away from lead PD-L1 drug
Fierce Biotech
Tue, 05/14/19 - 11:36 pm
Merck KGaA
bispecific antibodies
f-star
drug discovery
Xencor begins phase 1 trial of XmAb23104 in advanced solid tumors
Pharmaceutical Business Review
Fri, 05/10/19 - 10:46 am
Xencor
solid tumors
bispecific antibodies
clinical trials
XmAb23104
Regeneron’s star bispecific is linked to 2 deaths in a small study — which was no help for its Q1 call
Endpoints
Wed, 05/8/19 - 09:41 am
Regeneron
REGN1979
bispecific antibodies
Daiichi picks immuno-oncology bispecific, triggering payout to Zymeworks
Fierce Biotech
Thu, 04/25/19 - 11:45 am
Daiichi Sankyo
immuno-oncology
Zymeworks
bispecific antibodies
FDA draft guidance suggests comparing bispecifics to monospecific antibodies
BioCentury
Thu, 04/18/19 - 10:13 pm
FDA
bispecific antibodies
Xencor, Astellas Pharma collaborate on novel bispecific antibody program
Pharmaceutical Business Review
Wed, 04/3/19 - 10:00 am
Xencor
Astellas
R&D
bispecific antibodies
Deaths spur partial hold for Xencor’s CD3 bispecific for leukemia, partnered with Novartis in $2.5B deal
Endpoints
Wed, 02/20/19 - 10:00 am
Xencor
XmAb14045
bispecific antibodies
acute myeloid leukemia
Pages
« first
‹ previous
1
2
3
4
next ›
last »